Speciality European Pharma

Developer of medicines for urological conditions

placeLondon, England, United Kingdom calendar_todayFounded 2006 groups41 employees language specialityeuropeanpharma.com

Registered entities

Investor mix

6 investors on record; lead investors include ProVen VCT; 1 has since exited.

Investor typeCountShare
Venture capital233%
Private equity117%
Other / undisclosed350%
Coming soon